Cargando…

Epileptic seizures at multiple sclerosis onset and their role in disease progression

BACKGROUND: Epileptic seizures can occur throughout the course of multiple sclerosis (MS) and are associated with increasing disability progression over time. However, there are no data on whether epileptic seizures at the onset of MS also lead to increasing disability. OBJECTIVE: To examine disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Grothe, Matthias, Ellenberger, David, Rommer, Paulus S., Stahmann, Alexander, Zettl, Uwe K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559692/
https://www.ncbi.nlm.nih.gov/pubmed/37808247
http://dx.doi.org/10.1177/17562864231192826
_version_ 1785117559745413120
author Grothe, Matthias
Ellenberger, David
Rommer, Paulus S.
Stahmann, Alexander
Zettl, Uwe K.
author_facet Grothe, Matthias
Ellenberger, David
Rommer, Paulus S.
Stahmann, Alexander
Zettl, Uwe K.
author_sort Grothe, Matthias
collection PubMed
description BACKGROUND: Epileptic seizures can occur throughout the course of multiple sclerosis (MS) and are associated with increasing disability progression over time. However, there are no data on whether epileptic seizures at the onset of MS also lead to increasing disability. OBJECTIVE: To examine disease progression over time for MS patients with epileptic seizures at onset. METHODS: We analyzed the data of 30,713 patients on the German Multiple Sclerosis Register in a case–control study for more than 15 years. MS patients with seizures at onset were further divided into subgroups with polysymptomatic and monosymptomatic onset to assess the impact of additional symptoms on disease progression. RESULTS: A total of 46 patients had seizures as onset symptoms. Expanded Disability Status Scale (EDSS) within the first year was lower in the group with seizures at onset compared to controls (0.75 versus 1.6, p < 0.05), which changed until the last reported visit (3.11 versus 3.0). Both subgroups revealed increased EDSS progression over time compared to controls. CONCLUSION: Epileptic seizures at MS onset are associated with a higher amount of disability progression over time. Additional longitudinal data are needed to further clarify the impact of seizures on the pathophysiology of MS disease progression.
format Online
Article
Text
id pubmed-10559692
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-105596922023-10-08 Epileptic seizures at multiple sclerosis onset and their role in disease progression Grothe, Matthias Ellenberger, David Rommer, Paulus S. Stahmann, Alexander Zettl, Uwe K. Ther Adv Neurol Disord Original Research BACKGROUND: Epileptic seizures can occur throughout the course of multiple sclerosis (MS) and are associated with increasing disability progression over time. However, there are no data on whether epileptic seizures at the onset of MS also lead to increasing disability. OBJECTIVE: To examine disease progression over time for MS patients with epileptic seizures at onset. METHODS: We analyzed the data of 30,713 patients on the German Multiple Sclerosis Register in a case–control study for more than 15 years. MS patients with seizures at onset were further divided into subgroups with polysymptomatic and monosymptomatic onset to assess the impact of additional symptoms on disease progression. RESULTS: A total of 46 patients had seizures as onset symptoms. Expanded Disability Status Scale (EDSS) within the first year was lower in the group with seizures at onset compared to controls (0.75 versus 1.6, p < 0.05), which changed until the last reported visit (3.11 versus 3.0). Both subgroups revealed increased EDSS progression over time compared to controls. CONCLUSION: Epileptic seizures at MS onset are associated with a higher amount of disability progression over time. Additional longitudinal data are needed to further clarify the impact of seizures on the pathophysiology of MS disease progression. SAGE Publications 2023-10-06 /pmc/articles/PMC10559692/ /pubmed/37808247 http://dx.doi.org/10.1177/17562864231192826 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Grothe, Matthias
Ellenberger, David
Rommer, Paulus S.
Stahmann, Alexander
Zettl, Uwe K.
Epileptic seizures at multiple sclerosis onset and their role in disease progression
title Epileptic seizures at multiple sclerosis onset and their role in disease progression
title_full Epileptic seizures at multiple sclerosis onset and their role in disease progression
title_fullStr Epileptic seizures at multiple sclerosis onset and their role in disease progression
title_full_unstemmed Epileptic seizures at multiple sclerosis onset and their role in disease progression
title_short Epileptic seizures at multiple sclerosis onset and their role in disease progression
title_sort epileptic seizures at multiple sclerosis onset and their role in disease progression
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559692/
https://www.ncbi.nlm.nih.gov/pubmed/37808247
http://dx.doi.org/10.1177/17562864231192826
work_keys_str_mv AT grothematthias epilepticseizuresatmultiplesclerosisonsetandtheirroleindiseaseprogression
AT ellenbergerdavid epilepticseizuresatmultiplesclerosisonsetandtheirroleindiseaseprogression
AT rommerpauluss epilepticseizuresatmultiplesclerosisonsetandtheirroleindiseaseprogression
AT stahmannalexander epilepticseizuresatmultiplesclerosisonsetandtheirroleindiseaseprogression
AT zettluwek epilepticseizuresatmultiplesclerosisonsetandtheirroleindiseaseprogression